Penserra Capital Management LLC Pfizer Inc Transaction History

Penserra Capital Management LLC

$7.9 Billion
Q2 2024

A detailed history of Penserra Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Penserra Capital Management LLC holds 5,642 shares of PFE stock, worth $154,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,642

Previous 459 1129.19%

Holding current value

$154,929

Previous $12,000 1216.67%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $130,922 - $153,416	5,183 Added 1129.19%	5,642 $158,000
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $664,492 - $763,050	-25,666 Reduced 98.24%	459 $12,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $143,349 - $186,194	-5,486 Reduced 17.35%	26,125 $751,000
Q3 2023 Nov 15, 2023	SELL	$32.09 - $37.51 $158,877 - $185,712	-4,951 Reduced 13.54%	31,611 $1.05 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $1.27 Million - $1.46 Million	35,044 Added 2308.56%	36,562 $1.34 Million
Q1 2023 Apr 24, 2023	SELL	$39.39 - $51.28 $464,092 - $604,180	-11,782 Reduced 88.59%	1,518 $61,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $555,275 - $724,850	13,300 New	13,300 $680,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $833,631 - $988,425	-17,916 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $525,027 - $650,574	11,476 Added 178.2%	17,916 $926,000
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $266,100 - $394,450	6,440 New	6,440 $380,000
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $74,705 - $94,993	-2,232 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $6,731 - $7,897	-212 Reduced 8.67%	2,232 $81,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $12,228 - $14,835	-406 Reduced 14.25%	2,444 $79,000
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $8,163 - $11,663	302 Added 11.85%	2,850 $106,000
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $16,163 - $18,343	491 Added 23.87%	2,548 $95,000
Q3 2019 Nov 15, 2019	SELL	$32.49 - $42.13 $873,331 - $1.13 Million	-26,880 Reduced 92.89%	2,057 $73,000
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $106,132 - $119,162	2,870 Added 11.01%	28,937 $1.25 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $214,612 - $235,787	-5,723 Reduced 18.0%	26,067 $1.06 Million
Q4 2018 Feb 06, 2019	SELL	$38.47 - $43.86 $344,883 - $393,204	-8,965 Reduced 22.0%	31,790 $1.39 Million
Q3 2018 Nov 05, 2018	BUY	$34.47 - $41.81 $1.4 Million - $1.7 Million	40,755 New	40,755 $1.8 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Account

Penserra Capital Management LLC Pfizer Inc Transaction History